发明名称 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation
摘要 <CHEM> wherein A is O, S, CHR<1> or NR<2>, R<1> and R<2> are H, lower alkyl, X<1> and X<2> are H, halogen, nitro, cyano, etc., Y<1> is H, lower alkyl, Z<1> and Z<2> are H, halogen, cyano, hydroxy, lower alkyl, etc., and n is an integer of 2 to 4, a pharmaceutically acceptable salt thereof, a process for preparing the same, a pharmaceutical composition containing the same as an active ingredient, and an intermediate therefor. The compounds (I) of the present invention show a potent PDE IV inhibitory activity as well as an excellent bronchodilating activity, and hence, they are widely useful as a PDE IV inhibitor in the treatment or prophylaxis of allergic inflammatory diseases or organ inflammatory diseases, especially in the treatment or prophylaxis of pulmonary diseases accompanied by airway obstruction such as asthma.
申请公布号 AU6000099(A) 申请公布日期 2000.04.26
申请号 AU19990060000 申请日期 1999.09.30
申请人 DAINIPPON PHARMACEUTICAL CO. LTD. 发明人 MOTOJI KAWASAKI;TOMOHIRO NIGO;TADASHI NOBATA;SHUNYA NAKAMURA;MARI ITOH
分类号 C07D401/12;A61K31/4425;A61P11/06;A61P11/08;A61P43/00;C07D213/30;C07D213/64;C07D213/643;C07D213/65;C07D213/69;C07D213/70;C07D213/71;C07D213/73;C07D213/74;C07D213/75;C07D213/76;C07D213/80;C07D213/82;C07D213/85;C07D401/14 主分类号 C07D401/12
代理机构 代理人
主权项
地址